A detailed history of Allianz Asset Management Gmb H transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 50,000 shares of ADMA stock, worth $748,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,000
Previous 16,106 210.44%
Holding current value
$748,500
Previous $319,000 185.27%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025

BUY
$17.6 - $24.51 $596,534 - $830,741
33,894 Added 210.44%
50,000 $910,000
Q1 2025

May 05, 2025

BUY
$15.44 - $20.61 $248,676 - $331,944
16,106 New
16,106 $319,000
Q3 2024

Nov 12, 2024

BUY
$11.21 - $20.03 $263,502 - $470,825
23,506 New
23,506 $469,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $2.94B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.